Financials

  • Market Capitalization 447.63 M
  • Employee 116
  • Founded 2013
  • CEO Shankar Musunuri
  • Website www.ocugen.com
  • Headquarter Delaware, United States
  • FIGI BBG00194VJB1
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-5.88
Fiyat/satışlar oranı
106.63

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
2981
AGMB
AgomAb Therapeutics NV - ADRs representing one
13.17 USD-4.84%-0.30%+3.21%-10.41%449.98 M USD
2983
DNA
Ginkgo Bioworks Holdings, Inc. Class A Common Stock
6.98 USD-3.99%-4.12%-14.46%-21.40%449.10 M USD
2988
RZLT
Rezolute, Inc. - Common Stock
4.62 USD-7.23%-8.15%-5.91%-35.11%444.87 M USD
3011
PRLD
Prelude Therapeutics Incorporated - Common Stock
5.47 USD-13.72%-17.50%+7.89%+355.83%436.53 M USD

Haberler